PubMed=23161805; DOI=10.1002/emmm.201201973
Jacquet L., Stephenson E., Collins R., Patel H., Trussler J., Al-Bedaery R., Renwick P., Ogilvie C.M., Vaughan R., Ilic D.
Strategy for the creation of clinical grade hESC line banks that HLA-match a target population.
EMBO Mol. Med. 5:10-17(2013)

PubMed=26607962; DOI=10.1038/srep17258
Canham M.A., Van Deusen A.L., Brison D.R., De Sousa P.A., Downie J.M., Devito L.G., Hewitt Z.A., Ilic D., Kimber S.J., Moore H.D., Murray H., Kunath T.
The molecular karyotype of 25 clinical-grade human embryonic stem cell lines.
Sci. Rep. 5:17258-17258(2015)

PubMed=27345806; DOI=10.1016/j.scr.2015.12.036
Devito L.G., Wood V., Kadeva N., Cornwell G., Codognotto S., Stephenson E., Ilic D.
Generation of KCL039 clinical grade human embryonic stem cell line.
Stem Cell Res. 16:170-172(2016)

PubMed=28445466; DOI=10.1038/nature22312
Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C., Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G., Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A., Eggan K.C.
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations.
Nature 545:229-233(2017)